Xiaofei Li

2.1k total citations
43 papers, 797 citations indexed

About

Xiaofei Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xiaofei Li has authored 43 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 7 papers in Surgery. Recurrent topics in Xiaofei Li's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Xiaofei Li is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Xiaofei Li collaborates with scholars based in China, Netherlands and United States. Xiaofei Li's co-authors include Weimin Mao, Chun Chen, Lanjun Zhang, Shidong Xu, Yi Shen, Heng Zhao, Qun Wang, Yongyu Liu, Dongsheng Yue and Yue Yang and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and Annals of Oncology.

In The Last Decade

Xiaofei Li

42 papers receiving 788 citations

Peers

Countries citing papers authored by Xiaofei Li

Since Specialization

Citations

This map shows the geographic impact of Xiaofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Li more than expected).

Fields of papers citing papers by Xiaofei Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Li. The network helps show where Xiaofei Li may publish in the future.

Co-authorship network of co-authors of Xiaofei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Li. A scholar is included among the top collaborators of Xiaofei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Li. Xiaofei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Multifunctional piezoelectric hydrogels under ultrasound stimulation boost chondrogenesis by recruiting autologous stem cells and activating the Ca2+/CaM/CaN signaling pathway	Bioactive Materials	Yubao Liu, Xu Liu et al.	2
2	Ultrasmall Prussian Blue Nanozyme Attenuates Osteoarthritis by Scavenging Reactive Oxygen Species and Regulating Macrophage Phenotype	Nano Letters	Xiaofei Li, Qian Liu et al.	22
3	84P Adebrelimab plus chemotherapy (chemo) as first-line treatment for extensive-stage small-cell lung cancer (ES-SCLC): 3-year update of the phase III CAPSTONE-1 study	Immuno-Oncology Technology	Ying Cheng, Caicun Zhou et al.	2
4	Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer	Journal of Clinical Oncology	Dongsheng Yue, Shidong Xu et al.	37
5	[Clinicopathological features of clear cell carcinoma of salivary gland in the head and neck].	PubMed	Sha Zhao, Yan Zhu et al.	1
6	Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations	Translational Lung Cancer Research	Kai Guo, Changjian Shao et al.	14
7	Predictive efficacy of weaning index on mechanical ventilation evacuation	Annals of Palliative Medicine	Yan Huo, Kun Zhang et al.	4
8	[Clinicopathological study of large B-cell lymphoma with IRF4 rearrangement].	PubMed	Xiaofei Li, Guoxin Song et al.	2
9	Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel‐Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta‐Analysis of 36 Randomized Controlled Trials	Evidence-based Complementary and Alternative Medicine	Zheng Xiao, Cheng-Qiong Wang et al.	16
10	Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines	Journal of Ethnopharmacology	Zheng Xiao, Cheng-Qiong Wang et al.	44
11	Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation	Biologics	Ying Sun, Xuejiao Wang et al.	21
12	Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial	The Lancet Respiratory Medicine	Dongsheng Yue, Shidong Xu et al.	177
13	The safety and effectiveness of robot-assisted versus laparoscopic TME in patients with rectal cancer	Medicine	Xiaofei Li, Tao Wang et al.	55
14	Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer	Journal of Thoracic Disease	Kang Guo, Wuping Wang et al.	13
15	Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer	Oncology Reports	Ying Sun, Yong Han et al.	24
16	Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer	OncoTargets and Therapy	Xuejiao Wang, Ying Sun et al.	19
17	Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.	PubMed	Yan Yang, Xiufang Cui et al.	23
18	Prevalence of left and balanced coronary arterial dominance decreases with increasing age of patients at autopsy. A postmortem coronary angiograms study	Cardiovascular Pathology	Max Knaapen, Charlotte Koch et al.	32
19	Detection of EGFR Mutation in Tissue Samples of Non–small-cell Lung Cancer by a Fluorescence Polarization Assay	Diagnostic Molecular Pathology	Wenchao Liu, Xiaofei Li et al.	4
20	Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer.	Tumori	Yan Li, Rong‐Miao Zhou et al.	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact